K012283 · Safegard Medical Products, Inc. · FMI · Oct 1, 2001 · General Hospital
Device Facts
Record ID
K012283
Device Name
SOLOGARD LOCKING PLUS SYRINGE WITH NEEDLE
Applicant
Safegard Medical Products, Inc.
Product Code
FMI · General Hospital
Decision Date
Oct 1, 2001
Decision
SESE
Submission Type
Traditional
Regulation
21 CFR 880.5570
Device Class
Class 2
Indications for Use
These syringes are intended for use by health care professionals for general purpose fluid aspiration/injection. The devices contain a piston locking mechanism which aids in the prevention of the accidental reuse of the syringe.
Device Story
SOLOGARD® LOCKING PLUS Syringe with Needle is a sterile, single-use, disposable hypodermic syringe. Device incorporates a plunger locking mechanism that engages after depression to prevent plunger withdrawal and accidental reuse. Available in 1, 2.5, 3, 5, and 10 ml sizes; supplied with G29 x ½" or G29 x 5/8" needle. Used by healthcare professionals in clinical settings for standard fluid aspiration and injection tasks. Locking feature provides safety benefit by mitigating needle-stick and cross-contamination risks associated with syringe reuse.
Clinical Evidence
Bench testing only.
Technological Characteristics
Piston syringe with integrated plunger locking mechanism. Sizes: 1, 2.5, 3, 5, 10 ml. Needles: G29 x ½" or G29 x 5/8". Sterile, single-use, disposable. Mechanical operation.
Indications for Use
Indicated for use by health care professionals for general purpose fluid aspiration/injection.
Regulatory Classification
Identification
A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.
Predicate Devices
Becton Dickinson Single Use Hypodermic Syringes
SafeGard Medical Products, Inc. SOLOGARD® LOCKING PLUS Syringe without Needle
Submission Summary (Full Text)
{0}------------------------------------------------
# OCT = 1 2001
# 510(k) Summary of Safety and Effectiveness For SOLOGARD® LOCKING PLUS Syringe with Needle
July 18, 2001
#### CONTACT PERSON:
Patrick Grant, Jr. SafeGard Medical Products, Inc. 52 Dragon Court Woburn, MA 01801 Phone: (781) 935-2275 Fax: (781) 935-8424
#### DEVICE NAME:
Trade name: SOLOGARD® LOCKING PLUS Syringe with Needle Common & Classification name: Piston Syringe
#### PREDICATE DEVICES:
Becton Dickinson Single Use Hypodermic Syringes and SafeGard Medical Products, Inc. SOLOGARD® LOCKING PLUS Syringe without Needle
#### PRODUCT DESCRIPTION:
The SOLOGARD® LOCKING PLUS Syringe is a sterile, single-use, disposable hypodermic syringe with a plunger locking feature to prevent the accidental reuse of the syringe. It is manufactured in sizes of 1, 2.5, 3, 5, & 10 ml and is supplied with a G29 x ½" or G29 x 5/8" needle.
#### INTENDED USE:
The syringe is intended for use by health care professionals for general purpose fluid aspiration/injection.
#### COMPARISON TO PREDICATE DEVICES:
The SOLOGARD® LOCKING PLUS Syringe with needle is designed with a locking feature which detains the plunger after it is depressed and prevents the plunger withdrawal for a subsequent accidental reuse. In this aspect it is similar to the predicate SOLOGARD® LOCKING PLUS Syringe without Needle.
{1}------------------------------------------------
All other aspects of the design do not vary significantly from the predicate Becton Dickinson device.
### EQUIVALENCE:
The performance and use of this device do not differ significantly from the predicate devices. Therefore, SafeGard Medical Products, Inc. believes that this device is equivalent to the predicate devices.
{2}------------------------------------------------
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines representing its wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle.
Public Health Service
OCT - 1 2001
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Patrick Grant, Jr. President Safegard Medical Products, Incorporated 52 Dragon Court Woburn, Massachusetts 01801
Re: K012283
Trade/Device Name: Sologard Locking Plus Syringe with Needle Regulation Number: 880.5860 and 880.5570 Regulation Name: Piston Syringe Regulatory Class: II Product Code: FMF and FMI Dated: July 18, 2001 Received: July 20, 2001
Dear Mr. Grant:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
{3}------------------------------------------------
Page 2 - Mr. Grant
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice und instills (21 CF Partier in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and aller reville) over at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
L. Alatorre
A. Ulatowski Tim Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{4}------------------------------------------------
### Indications for Use Statement
510(k) Number (if known): _ K 0 1 22 8 3
Device Name: _SOLOGARD® Locking Plus Syringe with Needle
Indications For Use:
These syringes are intended for use by health care professionals for general purpose fluid aspiration/injection. The devices contain a piston locking mechanism which aids in the prevention of the accidental reuse of the syringe.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use _________________________________________________________________________________________________________________________________________________________
Patricia Cescente
(Division Sign-Off) Division of Dental, Infection Control, and General Hospital Devices 510(k) Number _ 4 012
(Optional Format 1-2-96)